D. E. Shaw & Co. Inc. Sells 629,378 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

D. E. Shaw & Co. Inc. reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 62.8% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 373,427 shares of the exchange traded fund’s stock after selling 629,378 shares during the period. D. E. Shaw & Co. Inc. owned about 0.49% of SPDR S&P Biotech ETF worth $33,631,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC boosted its holdings in SPDR S&P Biotech ETF by 1.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 120,504 shares of the exchange traded fund’s stock worth $11,906,000 after purchasing an additional 1,941 shares during the last quarter. ST Germain D J Co. Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $108,000. Fulcrum Capital LLC boosted its stake in shares of SPDR S&P Biotech ETF by 3.1% in the 4th quarter. Fulcrum Capital LLC now owns 49,666 shares of the exchange traded fund’s stock worth $4,473,000 after buying an additional 1,470 shares during the last quarter. Global Financial Private Client LLC grew its holdings in shares of SPDR S&P Biotech ETF by 8.5% in the fourth quarter. Global Financial Private Client LLC now owns 9,326 shares of the exchange traded fund’s stock valued at $840,000 after acquiring an additional 727 shares in the last quarter. Finally, Fortis Advisors LLC increased its position in shares of SPDR S&P Biotech ETF by 12.3% during the fourth quarter. Fortis Advisors LLC now owns 5,950 shares of the exchange traded fund’s stock valued at $536,000 after acquiring an additional 650 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 2.1 %

XBI stock opened at $76.39 on Friday. The stock has a market cap of $4.85 billion, a P/E ratio of 11.47 and a beta of 1.00. The stock’s fifty day simple moving average is $80.77 and its two-hundred day simple moving average is $89.22. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.